Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 2
2006 2
2007 2
2008 4
2009 3
2010 4
2011 2
2012 2
2013 8
2014 3
2015 6
2016 4
2017 12
2018 9
2019 9
2020 11
2021 11
2022 8
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
The p66Shc Redox Protein and the Emerging Complications of Diabetes.
Biondi G, Marrano N, Borrelli A, Rella M, D'Oria R, Genchi VA, Caccioppoli C, Cignarelli A, Perrini S, Laviola L, Giorgino F, Natalicchio A. Biondi G, et al. Among authors: laviola l. Int J Mol Sci. 2023 Dec 20;25(1):108. doi: 10.3390/ijms25010108. Int J Mol Sci. 2023. PMID: 38203279 Free PMC article. Review.
Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis.
Caruso I, Di Gioia L, Di Molfetta S, Cignarelli A, Palmer SC, Natale P, Strippoli GFM, Perrini S, Natalicchio A, Laviola L, Giorgino F. Caruso I, et al. Among authors: laviola l. EClinicalMedicine. 2023 Sep 12;64:102181. doi: 10.1016/j.eclinm.2023.102181. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37719418 Free PMC article.
Evaluation of a digital tool supporting therapeutic decision making for the personalized management of patients with type 2 diabetes not treated with insulin: A pilot study.
Di Molfetta S, Laviola L, Natalicchio A, Leonardini A, Cignarelli A, Bonizzoni E, Acmet E, Giorgino F. Di Molfetta S, et al. Among authors: laviola l. Diabetes Res Clin Pract. 2023 Sep;203:110836. doi: 10.1016/j.diabres.2023.110836. Epub 2023 Jul 20. Diabetes Res Clin Pract. 2023. PMID: 37478979 Free article. Clinical Trial.
Glucagon in type 2 diabetes: Friend or foe?
Caruso I, Marrano N, Biondi G, Genchi VA, D'Oria R, Sorice GP, Perrini S, Cignarelli A, Natalicchio A, Laviola L, Giorgino F. Caruso I, et al. Among authors: laviola l. Diabetes Metab Res Rev. 2023 Mar;39(3):e3609. doi: 10.1002/dmrr.3609. Epub 2023 Jan 30. Diabetes Metab Res Rev. 2023. PMID: 36637256 Review.
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes.
Orsi E, Solini A, Penno G, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Haxhi J, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group. Orsi E, et al. Cardiovasc Diabetol. 2022 Dec 2;21(1):266. doi: 10.1186/s12933-022-01706-2. Cardiovasc Diabetol. 2022. PMID: 36461034 Free PMC article.
101 results